05 Jul Public-Private Partnerships Aim to Bolster ‘Cancer Moonshot’ Initiative
Vice President Joe Biden gave the opening remarks at the Cancer Moonshot summit in Washington, and spoke of his decision not to run for president. Photo: AP
Wall Street Journal
By THOMAS M. BURTON
WASHINGTON—Vice President Joe Biden announced a series of partnerships involving government, industry and academia that are aimed at bolstering the White House’s proposed $1 billion “cancer moonshot” to speed up the national fight against the disease.
The alliances were disclosed Wednesday at the outset of more than 270 events around the country to kick off the cancer effort, including a meeting at Howard University in Washington, D.C., billed as the Cancer Moonshot summit.
Biden and the White House are a partnership between the National Cancer Institute and at least 20 drug and biotechnology companies to expedite researchers’ access to drugs, both investigational and approved.
The moonshot has been greeted in the medical community with considerable enthusiasm for the new research funding and collaboration, but also with skepticism that these steps alone would expedite research and treatment.
At Wednesday morning’s session, Mr. Biden said he had no illusions that his effort could end cancer quickly, but told researchers and patients in the audience he believed “we can make exponential progress, and make 10 years of progress in five years.”